Clinical Trial Update: Effects of Kuvan on Melatonin Secretion [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of Kuvan (sapropterin dihydrochloride) on melatonin secretion in individuals with phenylketonuria has been completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• KUVAN (Sapropterin dihydrochloride)

Snippet

Sponsor: University of Southern California | Conditions: Phenylketonuria (PKU) | Phase 4 | Status: COMPLETED | Results posted: 2016-11-18